This blog post highlights how empathy mapping and patient-centered strategies can transform clinical trials by better understanding and addressing the real-world challenges patients face, especially in rare diseases. It outlines how approaches like decentralized trials, adaptive designs, and partnerships with patient organizations help improve accessibility, engagement and outcomes.